From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

First U.S. MERS-CoV Patient to be Released from Hospital

by Global Biodefense Staff
May 7, 2014
Coronavirus

Colorized transmission electron micrograph of the Middle East respiratory syndrome coronavirus. Credit: NIAID

The man hospitalized in Indiana with the first U.S. case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is improving and could be released from the hospital soon.

Indiana State Department of Health Commissioner William VanNess II, Governor Mike Pence, and CDC and hospital officials updated the media on Monday, saying none of the more than 50 health-care workers and family members who’ve had contact with the patient have tested positive for the virus. MERS-CoV has an incubation period of up to 14 days.

The infected patient had traveled by plane from Riyadh, Saudi Arabia to Chicago, Illinois on April 24, 2014.  He then traveled by bus from Chicago to Indiana. Several days later, he began to experience respiratory symptoms, including shortness of breath, coughing, and fever. He went to the emergency department on April 28th and was admitted on that same day.

Health officials have reportedly contacted a large number of the passengers who traveled on the same flight or bus as the infected patient and none has reported symptoms of the coronavirus.

At least 400 cases of MERS have been reported in the past two years, and more than 100 people have died.

“In this interconnected world we live in, we expected MERS to make its way to the United States,” Dr. Tom Frieden, director of the CDC, said during press conference Friday. “We have been preparing since 2012 for this possibility.”

From Our Partners
Tags: CoronavirusEmerging ThreatsMERS-CoV

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC